Table 3

Nationwide estimates for the UK and Denmark of the number of IS cases potentially occurring among patients with AF who had discontinued OAC therapy at the time of stroke

IS cases in last full year of follow-up† who were OAC discontinuers at the time of strokePopulation of IMRD-UK/RSD aged 20–89 yearsNationwide population aged 20–89 years*Multiplicative factorEstimated number of IS cases nationwide among OAC discontinuers
UK632 125 08049 948 64523.5
(49 948 645/2 125 080)
1481
(63×23.5)
Denmark42932 7694 430 0004.7
(4 430 000/932 769)
198
(42×4.7)
  • *Data for first quarter of 2018 used from Statistics Denmark.

  • †2017 UK, 2018 Denmark.

  • AF, atrial fibrillation; IMRD-UK, IQVIA Medical Research Data-UK; IS, ischaemic stroke; OAC, oral anticoagulant; RSD, Region of Southern Denmark.;